Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Table 3

Severity of diabetic retinopathy. Number of eyes per severity level before and after treatment in the three groups. Inactive PDR refers to eyes with complete regression of the new vessels after treatment.

	PRP group			IVT group			IVB group
	Basal	2 months	6 months	Basal	2 months	6 months	Basal	2 months	6 months
Inactive PDR	—	5	3	—	10	9	—	16	6
Mild PDR	5	7	9	9	7	7	3	1	11
Moderate PDR	10	4	4	6	2	3	8	0	1
High-risk PDR	3	2	2	5	1	0	6	1	0
Advanced high-risk PDR	2	2	1	0	0	0	2	1	1

IVB: intravitreal bevacizumab; IVT: intravitreal triamcinolone; PDR: proliferative diabetic retinopathy; PRP: panretinal photocoagulation.